Top atopic dermatitis news of 2023
Click Here to Manage Email Alerts
Healio’s top atopic dermatitis stories described evidence supporting various treatments, including two reviews of dozens of approaches, as well as physical and mental comorbidities, among other topics.
Atopic dermatitis treatment reduces food allergy among infants but inhibits growth
The use of topical corticosteroids to treat atopic dermatitis in infants also may help prevent hen’s egg allergy, but it may inhibit the baby’s growth as well, researchers wrote in The Journal of Allergy & Clinical Immunology. Also, Donald Y.M. Leung, MD, PhD, of National Jewish Health, shares his Perspective. Read more.
Atopic dermatitis may be associated with schizophrenia, schizoaffective disorder
Atopic dermatitis was associated with increased odds for schizophrenia and schizoaffective disorder, and physicians should recognize these associations and collaborate with other providers as needed, Jeffrey M. Cohen, MD, of Yale University School of Medicine, told Healio. Also, Jeffrey A. Lieberman, MD, of Columbia University Vagelos College of Physicians and Surgeons, and Benjamin Ungar, MD, of Icahn School of Medicine at Mount Sinai, share their Perspectives. Read more.
Prevalence of current eczema increasing among children, adolescents
The prevalence of current eczema increased by 0.98% per decade among adolescents and 1.21% per decade among children over a span of 27 years, Sinéad Máire Langan, FRCP, MSc, PhD, of London School of Hygiene & Tropical Medicine, told Healio. Also, Ungar again shares his Perspective. Read more.
Gut microbiome changes precede eczema development in infancy
Changes in the gut microbiota of infants preceded the development of eczema, but interventions that target key bacteria may prevent or mitigate later eczema, researchers wrote in mSystems. Read more.
FDA approves expanded use of Cibinqo for adolescents with atopic dermatitis
The FDA approved a supplemental new drug application to expand the use of abrocitinib (Cibinqo, Pfizer) for adolescents with atopic dermatitis when other systemic drug products are not adequate or advisable, according to a press release. Also, Peter A. Lio, MD, of Northwestern University Feinberg School of Medicine, shares his Perspective. Read more.
Ruxolitinib cream safe, effective for children with atopic dermatitis
Treatment with ruxolitinib (Opzelura, Incyte Dermatology) cream was well tolerated and effective with no effect on blood counts or bone growth among children with atopic dermatitis, researchers wrote in Annals of Allergy, Asthma & Immunology. Also, Brian S. Kim, MD, MTR, of Icahn School of Medicine at Mount Sinai, shares his Perspective. Read more.
Reviews weigh benefits, harms of topical, systemic treatments for atopic dermatitis
With dozens of topical therapies and systemic treatments available for atopic dermatitis, clinicians have many options, Derek K. Chu, MD, PhD, of McMaster University, told Healio, but a pair of reviews in The Journal of Allergy and Clinical Immunology may help them narrow down their choices. Read more.
Comorbidities add treatment burdens to atopic dermatitis
Patients with atopic dermatitis with comorbidities face additional treatment burdens and barriers, such as polypharmacy, access to care and costs, Wendy Smith Begolka, MBS, of the National Eczema Association, told Healio. Also, Nicholas Gulati, MD, PhD, of Icahn School of Medicine at Mount Sinai, shares his Perspective. Read more.
Black children with eczema less likely to undergo testing to confirm food allergy
Non-Hispanic Black children with eczema appeared significantly less likely to undergo skin and blood testing to confirm a food allergy compared with white children, even though non-Hispanic Black children have higher rates of food allergy than white children, Manali Shah, MD, of Rush University Medical Center, told Healio. Read more.
Poor mental health found to be common comorbidity with atopic dermatitis
Patients with atopic dermatitis have an increased likelihood of developing anxiety and depression, emphasizing the value and importance of patient-centered approaches to care, Allison Loiselle, PhD, of the National Eczema Association, told Healio. Read more.